![Glen Clack](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Glen Clack
Chief Tech/Sci/R&D Officer at
THERACRYF PLC
Net worth: 11 323 $ as of 2026-08-30
Profile
Glen Clack is currently Chief Medical Officer at TheraCryf Plc since 2021.
Dr. Clack holds a doctorate from The University of Sheffield and an undergraduate degree from Royal Free Hospital School of Medicine.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
THERACRYF PLC 0.2% | 2026-09-08 | 4,388,888 ( 0.2% ) | 11 323 $ | 2026-08-30 |
Glen Clack active positions
| Companies | Position | Start |
|---|---|---|
| THERACRYF PLC | Chief Tech/Sci/R&D Officer | 2021-04-30 |
Training of Glen Clack
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
9
1st degree connections
3
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Evgen Pharma Plc
 Evgen Pharma Plc Medical/Nursing ServicesHealth Services Engages in the development of pharmaceutical products and focus on cancer & neurological disease | Health Services |
The University of Sheffield
 The University of Sheffield Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Royal Free Hospital School of Medicine
 Royal Free Hospital School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
- Stock Market
- Insiders
- Glen Clack
